Medicine

P. Galle, A. Forner, J. Llovet, V. Mazzaferro, F. Piscaglia, J. Raoul, P. Schirmacher, V. Vilgrain

2018.7.1JOURNAL OF HEPATOLOGY

DOI: 10.1016/j.jhep.2018.03.019

tlooto Summary

The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.

Abstract

Summary Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-related death globally. Hepatocellular carcinoma represents about 90% of primary liver cancers and constitutes a major global health problem. The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.

Citation format

GALLE, P., et al. EASL clinical practice guidelines: Management of hepatocellular carcinoma. JOURNAL OF HEPATOLOGY, 2018, 69 1: 182–236.